The beat and guidance raise signal improving commercial traction from new products. Watch for H2 2026 revenue growth to turn positive as headwinds annualize; the stock may continue to re-rate if sequential improvement persists.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 7 $4.76entry
- T+1 · 3mo ago −1.89%α −1.86% · $4.67
- T+5 · 3mo ago +0.63%α +0.23% · $4.79
- T+20 · 3mo ago +1.05%α +1.45% · $4.81
- T+60 · 16d ago −6.93%α −4.66% · $4.43
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Treace Medical Concepts reported Q2 2026 revenue of $45.4M (down 4% YoY but beating $43.9M consensus) and EPS of -$0.24 (beating -$0.30 consensus by 20%). The company raised full-year revenue guidance to $204M-$212M and improved Adjusted EBITDA loss guidance to $3M-$5M, while reducing year-to-date cash usage by 57%. New product adoption is accelerating, with 40% of Lapiplasty surgeons now using at least one of the three new bunion systems.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $45.4M vs $47.4M YoY (-4%), beating consensus of $43.9M
- Q2 2026 GAAP EPS -$0.24 vs -$0.28 YoY, beating consensus of -$0.30
- Full-year 2026 revenue guidance raised to $204M-$212M (from $202M-$212M)
- Adjusted EBITDA loss guidance improved to $3.0M-$5.0M (from $4.0M-$6.0M)
- Year-to-date cash usage reduced 57% vs prior year; cash + marketable securities $45.6M
- Gross margin 78.5% vs 79.7% YoY; operating expenses down 8% YoY
- 40% of Lapiplasty surgeons using ≥1 new bunion system (up from 35% in Q1 2026)
- New product launches: SuperBite Compression Screw and HyperPlate XM systems
Financial Impact
Revenue beat of ~$1.5M (3.4%) and EPS beat of $0.06 (20%) vs consensus; guidance raise narrows the decline range
Risk Factors
- Revenue still declining YoY (-4%) and company remains unprofitable
- Litigation costs ($2.1M in Q2) and restructuring charges ($0.8M) weigh on margins
- Macroeconomic headwinds could dampen elective bunion surgery demand
- Competition from minimally invasive bunion solutions may pressure market share
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001630627-26-000017 |
| Document: tmci-20260807.htm | 0001630627-26-000017 |
| Document: 0001630627-26-000017-index-headers.html | 0001630627-26-000017 |
| Document: 0001630627-26-000017-index.html | 0001630627-26-000017 |
| Document: 0001630627-26-000017.txt | 0001630627-26-000017 |
| 8-K Data (Synthetic) | 0001630627-26-000017 |
Track record
11 reports on TMCI
2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +12.39% at T+60 after the Jul 13, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago SC 13G Neutral 4/10 Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
- Nov 16, 20261d ago SC 13G/A Bearish 4/10 Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
- Nov 12, 20266d ago Court Ruling Neutral 4/10 Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
- Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
- Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
- Aug 7, 202614w ago 8-K Mixed 6/10 Viewing Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
- Jul 13, 202618w ago Court Ruling Bearish 5/10 Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
- May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
- Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
- Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers